James Hardiman - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock James Hardiman’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Digital Therapeutics,
- Genetics,
- Cybersecurity,
- DeepTech,
- Wellness,
- Enterprise Software,
- Computational Biology,
- Investment Management,
- Energy,
- Angel Investment,
- Life Science,
- Artificial Intelligence (AI),
- Robotics,
- Internet of Things (IoT),
- Geospatial Data,
- 3D Technology,
- Technology,
- Synthetic Biology,
- Finance,
- Automation,
- Software,
- Manufacturing,
- Biotechnology,
- Data Services,
- Genomics,
- IT Hardware,
- Precision Medicine,
- Innovation,
- Space Technology,
- Consumer Software,
- Early Stage IT,
- UK Startups,
- Utilities,
- Digital Health,
- Renewable Energy,
- Medical,
- Big Data,
- Information Technology,
- B2B,
- Defense,
- Advanced Materials,
- Machine Learning,
- Material Science,
- Pharmaceuticals,
- Healthcare Technology
Social media:
Past investments:
- Fortem Technologies
- Stealth Robotics Company
- Gradle Inc.
- Lumafield
- nTopology inc.
- Q-CTRL
- Shennon Biotechnologies
- Amogy
- Valar Labs
- Unlearn.AI
- Stealth TechBio Company
- Nium
- Semantic Health
- nTopology
- Subtle Medical
- Recursion Pharmaceuticals
- NOETIK
- Citrine Informatics
- Sequence Bio
Investor Profile
James Hardiman is a Venture Capital, Private Equity Firm, Angel/Individual, Investment Partner, Investor based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Fortem Technologies, Stealth Robotics Company, Gradle Inc., Lumafield, nTopology inc., Q-CTRL, Shennon Biotechnologies, Amogy, Valar Labs, Unlearn.AI, Stealth TechBio Company, Nium, Semantic Health, nTopology, Subtle MedicalRecursion Pharmaceuticals, NOETIK, Citrine Informatics, Sequence Bio, . Over time, James Hardiman has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether James Hardiman is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Digital Therapeutics, Genetics, Cybersecurity, DeepTech, Wellness, Enterprise Software, Computational Biology, Investment Management, Energy, Angel Investment, Life Science, Artificial Intelligence (AI), Robotics, Internet of Things (IoT), Geospatial Data, 3D Technology, Technology, Synthetic Biology, Finance, Automation, Software, Manufacturing, Biotechnology, Data Services, Genomics, IT Hardware, Precision Medicine, Innovation, Space Technology, Consumer Software, Early Stage IT, UK Startups, Utilities, Digital Health, Renewable Energy, Medical, Big Data, Information Technology, B2B, Defense, Advanced Materials, Machine Learning, Material Science, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with James Hardiman, as their portfolio suggests a familiarity and interest in this area.
Understanding James Hardiman’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
